| Product Code: ETC6660346 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Malaria Vaccine Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Malaria Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Malaria Vaccine Market - Industry Life Cycle |
3.4 Canada Malaria Vaccine Market - Porter's Five Forces |
3.5 Canada Malaria Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Canada Malaria Vaccine Market Revenues & Volume Share, By Agent, 2021 & 2031F |
3.7 Canada Malaria Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Canada Malaria Vaccine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Canada Malaria Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of malaria in Canada |
4.2.2 Government initiatives to eradicate malaria |
4.2.3 Growing awareness about the importance of vaccinations |
4.3 Market Restraints |
4.3.1 High costs associated with vaccine development and distribution |
4.3.2 Limited access to remote communities for vaccination programs |
5 Canada Malaria Vaccine Market Trends |
6 Canada Malaria Vaccine Market, By Types |
6.1 Canada Malaria Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Canada Malaria Vaccine Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Canada Malaria Vaccine Market Revenues & Volume, By Pre-Erythrocytic Vaccine, 2021- 2031F |
6.1.4 Canada Malaria Vaccine Market Revenues & Volume, By Erythrocytic Vaccine, 2021- 2031F |
6.1.5 Canada Malaria Vaccine Market Revenues & Volume, By Multi-Antigen Vaccine, 2021- 2031F |
6.2 Canada Malaria Vaccine Market, By Agent |
6.2.1 Overview and Analysis |
6.2.2 Canada Malaria Vaccine Market Revenues & Volume, By Plasmodium Falciparum, 2021- 2031F |
6.2.3 Canada Malaria Vaccine Market Revenues & Volume, By Plasmodium Vivax, 2021- 2031F |
6.2.4 Canada Malaria Vaccine Market Revenues & Volume, By Anopheles Species, 2021- 2031F |
6.3 Canada Malaria Vaccine Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Canada Malaria Vaccine Market Revenues & Volume, By Intramuscular, 2021- 2031F |
6.3.3 Canada Malaria Vaccine Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.4 Canada Malaria Vaccine Market Revenues & Volume, By Intradermal, 2021- 2031F |
6.4 Canada Malaria Vaccine Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Canada Malaria Vaccine Market Revenues & Volume, By NGO/Non-Profit Organization, 2021- 2031F |
6.4.3 Canada Malaria Vaccine Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.4 Canada Malaria Vaccine Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.4.5 Canada Malaria Vaccine Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Canada Malaria Vaccine Market Import-Export Trade Statistics |
7.1 Canada Malaria Vaccine Market Export to Major Countries |
7.2 Canada Malaria Vaccine Market Imports from Major Countries |
8 Canada Malaria Vaccine Market Key Performance Indicators |
8.1 Number of malaria cases reported annually in Canada |
8.2 Percentage of population vaccinated against malaria |
8.3 Funding allocated by the government for malaria eradication programs |
9 Canada Malaria Vaccine Market - Opportunity Assessment |
9.1 Canada Malaria Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Canada Malaria Vaccine Market Opportunity Assessment, By Agent, 2021 & 2031F |
9.3 Canada Malaria Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Canada Malaria Vaccine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Canada Malaria Vaccine Market - Competitive Landscape |
10.1 Canada Malaria Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Canada Malaria Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here